Human cutaneous mast cells in health and disease (III)

Nishinihon Journal of Dermatology

Volumn 59, Issue 6, 1997, Pages 864-869

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345672716     PISSN: 03869784     EISSN: 18804047     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.59.864     Document Type: Article

References (45)

1. Jacques P. et al: Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol 89: 1139-1143, 1992.
2. Hide E., Francis D.M., Grattan C.E.H.: Autoantibodies against the high affinity IgE receptor as a cause for histamine release in chronic urticaria. N Engl J Med 328: 1599–1604, 1993.
3. Mihm M.C. Jr et al: The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67: 305-312, 1976.
4. Johnson H.H. Jr et al: Skin histamine levels in chronic atopic dermatitis. J Invest Dermatol 34: 237-238, 1960.
5. Irani A.M.A., Sampson H.A. Schwartz L.B.: Mast cells in atopic dermatitis. Allergy 44, Suppl, 9: 31–34, 1989.
6. Ruzicka T., Gluck S.: Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome. Arch Dermatol Res 275: 41–44, 1983.
7. Sugiura H., Maeda T., Uehara M.: Mast cell invasion of peripheral nerve in skin lesion of atopic dermatitis. Arch Derm Venereol Suppl 176: 74–76, 1992.
8. Imayama S., Shibata Y., Hori Y.: Epidermal mast cells in atopic dermatitis. Lancet 346: 1559, 1995.
9. Kalimo K. et al: Mast cells and IgE in intestinal mucosa in adult atopic dermatitis patients. Br J Dermatol 119: 579–585, 1988.
10. Haas N. et al: Expression of the high affinity IgE-receptor on human Langerhans cells: elucidating the role of epidermal IgE in atopic eczema, Acta Derm Venereol 72: 271-272, 1992.
11. Gleich G.J.: The late phase of the immunoglobulin E mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol 70: 160–169. 1982.
12. Leiferman K. et al: Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N Engl J Med 313: 282–285. 1985.
13. Roupe G., Granerus G.: Increased urine histamine after challenge of contact sensitivity in the mouse. Acta Derm Venereol 59: 301–304, 1979.
14. Thomas W.R. et al: Antigen-specific mast cell degranulation in contact sensitivity to picryl chloride: an early event. Immunology 39: 331–336, 1980.
15. Wintroub B.U. et al: Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Eng J Med 298: 417–421, 1978.
16. Hebda P.A., Collins M.A., Tharp M.D.: Mast cell and myofi-broblast in wound healing. Dermatol Clin 11: 685-696, 1993.
17. Bolton L.L., Montagna W.: Mast cells in human ulcers. Am J Dermatopathol 15: 133–138, 1993.
18. Cohen I.K. et al: Histamine and collagen synthesis in keloid and hypertrophic scar. Surg Forurn 23: 509-510, 1972.
19. Kisher C.W., Bunce H. Shetlar M.R.: Mast cell analysis in hypertrophic scars, hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 70: 355–357, 1978.
20. Pearson M.E. et al: Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermis. Arthritis Rheum 31: 672–677, 1988.
21. Claman H.N.: Mast cell changes in a case of rapidly progressive scleroderma: ultrastrucural analysis. J Invest Dermatol 92: 290–295, 1989.
22. Seibold J.R., Glorno R.C., Claman H.N.: Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 33: 1702-1709, 1990.
23. Sheu H.-M. et al: Mast cell degranulation and elastolysis in the early stage of striae distensae. J Cutan Pathol 18: 410–416, 1991.
24. Riccardi V.M.: Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects 17: 129–145, 1981.
25. Riccardi V.M.: Mast-cell stabilization to decrease neurofibroma growth: preliminary experience with ketotifen. Arch Dermatol 123: 1011–1016, 1987.
26. Glowacki J., Mulliken J.B.: Mast cells in hemangiomas and vascular malformation. Pediatrics 70: 48–51, 1982.
27. Kessler D.A. et al: Mast cells and tumor angiogenesis. Int J Cancer 18: 703–709, 1976.
28. Azizkhan R.G. et al: Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 52: 931–944, 1980.
29. Folkman J. et al: Control of angiogenesis with sythetic heparin substitutes. Science 243: 1490-1493, 1989.
30. Marks R.M. et al: Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 55: 289–294, 1986.
31. Davis S. et al: isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161–1169, 1996.
32. Soter N.A.: Mast cells in cutaneous inflammatory disorders. J Invest Dermatol 80: 22S-25S, 1983.
33. Moretti G. et al: Histamine, serotonin and mast cells in the skin of rat during the hair cycle. J Invest Dermatol 40: 205–212. 1963.
34. Meyer K. et al: Effect of acid mucopolysaccharides on hair growth in the rabbit. Proc Soc Exp Biol Med 108: 59–63, 1961.
35. Maurer M., Paus R., Czarnetzki B.M.: Mast cells as modulators of hair follicle cycling. Exp Dermatol 4: 266–271, 1995.
36. Hibberts N.A., Messenger A.G., Randall V.A.: Dermal papilla cells derived from beard hair follicles secrete more stem cell factor (SCF) in culture than scalp cells or dermal fibroblasts. Riochem Biophys Res Commun 222: 401–405, 1996.
37. Kubota Y. et al: Characterization of expression and modulation od cell-surface antigens on cultured human dermal papilla cells: Hair Research for the Next Millenium, (Neste D.V. and Randall V.A. ed). Elsevier, Amsterdam, 417-420, 1996.
38. Matsuda H. et al: Necessity of IgE antibodies and mast cells for manifestation of resistance against larval HaemaPhysalis longicarnis ticks in mice. J Immunol 144: 259–262. 1990.
39. Kemp D.H., Bourne A.: Boophilus: the effect of histamine on the attachment of cattle-tick larvae-studies in vivo and in vitro, Parasitology 80: 487-496, 1980.
40. Zang Y. et al: Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258: 1957-1959, 1992.
41. Schubert C., Christophers E.: Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 277: 352–358, 1985.
42. Toruniowa B., Jablonska S.: Mast cells in the initial stages of psoriasis. Arch Dermatol Res 280: 189–193, 1988.
43. Tovry S. Fraki J. Tammi R.: Mast cell density in psoriatic skin. The effect of PUVA and corticosteroid therapy. Arch Dermatol Res 280: 282–285, 1988.
44. Harvima I.T. et al: Association of cutaneous mast cells and sensory nerves with psychicstress in psoriasis. Psychother Psychosom 60: 168-176, 1993.
45. Lichtig C. et al: Mast cells in Behcet’s disease: ultrastructural and histamine content studies. Dermatologica 162: 167-174, 1981.